Chaudhuri Sarbani
See Remarks
Chaudhuri Sarbani has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Aug 13, 2026.
On the most recent filing, Chaudhuri Sarbani is listed as See Remarks at ROCKET PHARMACEUTICALS, INC. Inside the rolling window, Chaudhuri Sarbani reported no open-market purchases and 2 open-market sales totaling $84K in RCKT. The largest disclosed transaction in the window is a sale of 17,650 RCKT shares on May 7, 2026, worth $68K.
Companies traded
Other insiders at RCKT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$84K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Chaudhuri Sarbani made?
Chaudhuri Sarbani has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.
Which companies does Chaudhuri Sarbani trade?
Chaudhuri Sarbani has filed SEC Form 4 disclosures for 1 company, including RCKT.
When was Chaudhuri Sarbani's most recent SEC Form 4 filing?
Chaudhuri Sarbani's most recent SEC Form 4 filing on Tracefour is dated Aug 13, 2026.
What is Chaudhuri Sarbani's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Chaudhuri Sarbani is listed as See Remarks.
What is Chaudhuri Sarbani's total buy and sell value in the current window?
Inside the rolling retention window, Chaudhuri Sarbani bought $0 and sold $84K based on SEC Form 4 filings.
What was Chaudhuri Sarbani's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 17,650 RCKT shares on 2026-05-07, worth $68K, per SEC Form 4 filings.